Organogenesis completes FDA submission for knee arthritis treatment

Go back to Organogenesis completes FDA submission for knee arthritis treatment
(NASDAQ: ORGO) Delayed: 2.40 -0.03 (1.23%)
Previous Close $2.43    52 Week High
Open $2.42    52 Week Low
Day High $2.45    P/E N/A 
Day Low $2.32    EPS
Volume 243,498